Background. Mycobacterium tuberculosis is a major cause of myelopathy and radiculopathy in settings with a high prevalence of tuberculosis/human immunodeficiency virus (HIV) coinfection. However, a paucity of publications exists on the spectrum of neurological and magnetic resonance (MR) imaging findings of spinal tuberculosis in these populations.
Central nervous system (CNS) tuberculosis includes involvement of the brain, such as tuberculous meningitis (TBM), tuberculoma/abscess, and cerebritis, and, less commonly, the spinal cord, including radiculomyelitis [1] , vertebral tuberculosis with neurological compromise [2] , and primary epidural abscess [3] . Several studies have reported tuberculosis as a major cause of myelopathy and or radiculopathy in settings with a high prevalence of human immunodeficiency virus (HIV)/tuberculosis coinfection [4] [5] [6] , accounting for 68% of HIV-infected patients (84 of 123) with myelopathy or cauda equina syndrome in whom an etiological cause was confirmed [4] . However, there is a paucity of literature on the clinical presentations and the spectrum of magnetic resonance (MR) imaging findings of spinal tuberculosis in HIV-infected patients [4, [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . Furthermore, there are only a few studies comparing these findings to those in HIV-uninfected patients [2, 8, 12] . Here we report the clinical, investigative, and MR imaging findings in adults with spinal tuberculosis in a setting with a high tuberculosis/HIV burden. We compare HIV-infected and HIV-uninfected patients and correlate clinical and cerebrospinal fluid (CSF) findings with those of spinal MR imaging.
METHODS
We conducted a retrospective study at Inkosi Albert Luthuli Central Hospital (IALCH), a public-sector referral facility in KwaZulu-Natal, South Africa. The hospital is the main referral center for patients with spinal disease without plain film radiographic evidence of bony involvement; those with bony disease are preferentially referred to the orthopedic spinal unit at King Dinuzulu Hospital (KDH). Hence, the study was biased toward nonbony spinal disease. We screened clinical records of all adults (aged ≥18 years) assessed with a diagnosis of tuberculosis involving the CNS and/or vertebral column from June 2003 through December 2015 at IALCH. Patients were identified based on International Classification of Diseases, 10th Revision, codes from the hospital's electronic record system (Supplementary Data).
We included patients who presented with new-onset myelopathy or radiculopathy and underwent MR imaging of the spine. Clinical data were extracted from hospital records. All MR images were reported by a neuroradiologist and reviewed by a neurologist. Results of tuberculosis and CSF investigations performed elsewhere and outcome (alive 9 months after admission) were obtained from the National Health Laboratories Service database. After diagnosis, patients with tuberculosis spondylitis were referred to KDH. We perused records at KDH for management and outcome (neurological disability) in these patients. The Biomedical Research Ethics Committee (BREC) of the University of KwaZulu-Natal approved the study (BREC class approval number BCA325/15).
Patients received tuberculosis treatment according to national tuberculosis guidelines for ≥9 months [16] and were prescribed prednisone at variable doses (starting dose, 40 mg/d to 1.5 mg/ kg/d) for 4-6 weeks. Since South Africa's national antiretroviral therapy (ART) program was implemented in 2004, all patients with neurological tuberculosis were eligible to start triple therapy. Tuberculosis treatment and ART were provided by and monitored at primary tuberculosis/HIV care facilities and district-level hospitals.
MR imaging was performed with a 1.5-or 3.0-T imager (Siemens Magnetom Aera 1.5 T TIM DOT System and Siemens Magnetom Skyra 3 T TIM DOT System). Sagittal and axial T1-weighted (T1W) and T2-weighted (T2W) imaging were routinely performed. Gadolinium-enhanced T1W imaging was performed in most patients.
DEFINITIONS

Clinical Definitions
Definite spinal tuberculosis was defined by positive results of microscopy, culture, histology, or Xpert MTB/RIF assay of any CNS sample. Probable spinal tuberculosis was defined as any of the following: (1) clinical or radiological improvement in neurological symptoms/signs after tuberculosis treatment initiation; (2) concomitant TBM [17] ; (3) spondylitis with the presence of extra-CNS tuberculosis (ie, Mycobacterium tuberculosis identified from an extra-CNS source or suggestive radiological features, eg, chest radiography) or with the patient alive at 9-month follow-up; (4) radiculomyelitis without spondylitis with features of extra-CNS tuberculosis plus exclusion of other causes by CSF examination for fungi, bacteria, viruses, cancer, and syphilis and appropriate blood tests. Patients were excluded if any of the following criteria were met: (1) undocumented spinal neurological findings; (2) neurological signs explained by findings of brain MR imaging; or (3) additional CNS infection, or noninfectious disease, identified or empirically treated.
Radiological Definitions
Spondylitis with or without diskitis was defined by any of the following: (1) abnormal vertebral signal (with or without abnormal disk signal) on T2W (hyperintense) and T1W (hypo/ isointense) images, with contrast enhancement if gadolinium was administered; (2) end-plate destruction; or (3) vertebral height loss/collapse, with or without disk destruction.
Myelitis was defined by a cord appearing hyperintense on T2W images and hypo-or isointense on T1W images, with or without cord expansion, along with (1) no cord compression (ie, subdural/epidural abscess or spondylitis) or (2) in case of cord compression, intramedullary enhancement. Meningoradiculitis was defined by any of the following: (1) spinal subarachnoid space loculations/obliteration; (2) nerve root thickening, nodularity, or clumping; or (3) spinal meningeal, root or subdural enhancement; radiculomyelitis was defined as meningoradiculitis and or myelitis. Subdural abscess was defined as a collection appearing iso/hypointense to the spinal cord on T1W images and of mixed signal intensity on T2W images with rim enhancement; this includes areas of T1 hypointensity (breakdown) within hypertrophic meninges and lesions in the subdural space that meet criteria for "liquefied tuberculoma" (defined below for intramedullary tuberculoma). (Note that "subdural tuberculoma" and "subdural abscess" are used interchangeably in the literature and may also be referred to as "subdural/intradural tuberculous granuloma" or "subdural/intradural "tuberculous empyema" [18] .)
Intramedullary tuberculoma was defined as a well-circumscribed intramedullary lesion appearing (1) hypointense on T1W and hyperintense on T2W images with homogeneous enhancement (solid, noncaseating); (2) isointense to hypointense on both T1W and T2W images with rim enhancement (caseating); or (3) hypointense on T1W images and hyperintense on T2W images with rim enhancement (liquefied). Syrinx was defined as an intramedullary lesion appearing isointense to CSF on T1W and T2W images without enhancement.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism software, version 6. Continuous variables are presented as medians and interquartile ranges (IQRs), and categorical variables as percentages. Categorical and continuous variables were compared between groups using Fisher exact and Mann-Whitney U tests, respectively. Differences were considered statistically significant at P < .05.
RESULTS
Baseline Characteristics
During the study period, 343 adults with spinal tuberculosis were assessed and underwent MR imaging of the spine. Figure 1 shows the reasons for study exclusion or inclusion. Of 274 included patients, the majority (73%) either had a diagnosis of definite neurological tuberculosis (n = 52) or showed clinical and or radiological improvement after tuberculosis treatment was initiated (n = 147). The baseline and outcome findings in the whole study group and in HIV-infected (n = 209; 76%) and HIV-uninfected (n = 49; 18%) patients are presented in Table 1 . The median CD4 cell count for HIV-infected patients was 175/μL (IQR, 100-292/μL). Of these patients, 53%
were receiving ART at presentation, for a median duration of 204 days (IQR. 40-593 days). Twenty-five patients were known to start ART a median of 20 days (IQR, 13-52 days) after starting tuberculosis treatment. HIV-uninfected patients presented more often with noncommunicable diseases (28% vs 8%; P <.001), including diabetes mellitus, that was present in 10% (Table 1 ). In 71 patients (26%), spinal symptoms developed during tuberculosis treatment; these included 62 HIV-infected and 8 HIV-uninfected patients and 1 with unknown HIV status; TBM was the initial disease presentation in 51, with improvement before presentation in 48. Reasons for deterioration in HIV-uninfected patients included paradoxical reaction (n = 7) [19] , manifesting a median of 27 days (IQR, 12-43) after initiation of tuberculosis treatment, and progressive deterioration of CNS tuberculosis (n = 1). Among HIV-infected patients, 16 of 62 had paradoxical tuberculosis-immune reconstitution inflammatory syndrome (IRIS) [20, 21] , occurring a median of 23 days (IQR, 12-40 days) after ART initiation. Among HIV-infected patients, 27 had paradoxical reactions unrelated to ART initiation, including 18 not receiving ART and 9 who were well established with ART before tuberculosis treatment; these events occurred a median of 31 days (IQR, 13-68 days) after tuberculosis treatment was initiated. In addition, 7 of 62 HIV-infected patients had paradoxical worsening after initiation of tuberculosis treatment and were receiving ART, but the date of ART initiation was unknown; 1 of 62 had progressive multidrug-resistant tuberculosis, and in 11 of 62 no specific cause could be identified owing to incomplete data (eg, incomplete data on compliance with treatment and ART). Although HIV-infected patients presented with some form of paradoxical reaction more frequently than HIVuninfected patients (24% vs 14%), this difference did not reach statistical significance (P = .18).
Clinical Findings
Limb weakness was present in 269 patients (98%) and most frequently involved lower limbs only (n = 213). The clinical presentation did not differ significantly between HIV-infected and uninfected patients (Table 1 ), but concomitant TBM was more common in HIV-coinfected patients (48% vs 29%; P = .02).
MR Imaging Findings
All patients underwent MR imaging of the whole spine except 1 who underwent imaging of the thoracolumbar spine only. Gadolinium-enhanced imaging was performed in 207 patients (76%). Spinal MR findings in the study group and by HIV status are presented in Table 2 . Radiculomyelitis was present in 210 patients (77%; Figure 2A and 2B) and spondylitis in 106 (39%). Of 163 patients (59%) who had radiculomyelitis without spondylitis, 24 had features of myelitis only. Seventy patients with radiculomyelitis had no associated TBM or spondylitis. Three patients without spondylitis had an epidural abscess ( Figure 2C ). Of those who underwent gadolinium-enhanced imaging, 42 (20%) had a In HIV-infected patients, noncommunicable diseases included hypertension (n = 11) and diabetes mellitus, Kaposi sarcoma, mixed mitral valve disease, hypothyroidism, chronic renal failure due to HIV-associated nephropathy, and asthma (each n = 1), In HIV-uninfected patients, they included diabetes mellitus (n = 5), hypertension (n = 5), mixed connective tissue disease (n = 2), and asthma, hypothyroidism, rheumatoid arthritis, and thalassemia minor (each n = 1); In patients with unknown HIV status, they included hypertension (n = 2) and diabetes mellitus (n = 1). subdural abscess (Figure 2D ), including 15 with tuberculoma ( Figure 2E ). Sixty-nine patients (33%) had intramedullary enhancement, of whom 33 (16%) had intramedullary tuberculoma ( Figure 2F ). Three patients presented with syrinx in addition to radiculomyelitis.
HIV-infected patients had radiculomyelitis more frequently (82% vs 59% in HIV-uninfected patients; P = .0012), whereas spondylitis was more common in HIV-uninfected patients (57% vs 33% in HIV-infected patients; P = .003). In patients with spondylitis, the number of vertebrae involved did not differ between the groups, but HIV-uninfected patients had more frequent loss of vertebral body height (22 of 27 [81%] vs 34 of 68 [50%] in HIV-infected patients; P = .006; Figure 2G and 2H). Two HIV-infected patients presented with unusual well-circumscribed round enhancing lesions in multiple vertebrae ( Figure 2I ). Brain imaging was performed in 96 patients (MR imaging in 62 and computed tomography in 34); contrast material was administered in 88%. Features of TBM seen in 76 patients (79%) included meningeal enhancement (n = 50), tuberculoma (n = 33), hydrocephalus (n = 27), and infarcts (n = 20).
Correlation Between Clinical and MR Imaging Findings
Supplementary Table S1 shows the clinical findings in patients with spondylitis (n = 106) compared with those in patients without bony disease (n = 168); patients with spondylitis were older (median age [IQR], 38 vs 31 [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] , years; P < .001) and had a longer symptom duration (47 vs 28 days; P = .004). The triad of neurological deficits, fever, and back pain, were seen in similar proportions of patients with spondylitis (24%), subdural/epidural abscess without bony disease (14%), meningoradiculitis (17%), and isolated myelitis (17%).
In 205 patients with cord involvement at MR imaging, 39 (19%) presented with an upper motor neuron (UMN) syndrome, 93 (45%) with a lower motor neuron (LMN) syndrome and 69 (34%) with mixed UMN and LMN signs. Spinal symptom duration varied according to these clinical presentations; patients with a pure UMN syndrome had the longest duration (median [IQR] , 91 /L) had the highest counts. Patients with subdural abscess had higher neutrophil counts than the other groups (P value range, .003 to <.001) and were more likely than those with radiculomyelitis to present with a neutrophil count ≥4 × 10 6 /L (79% vs 46%, respectively; P = .01).
Surgical Management, Follow-up and Outcome
Spinal biopsy and or decompressive surgery was performed in 44 patients with epi/subdural collections (n = 30), spondylitis (n = 13), or intramedullary lesions (n = 1). In addition to 57 patients who initially presented with a paradoxical reaction, 6 patients experienced paradoxical CNS worsening after study entry; 3 patients showed clinical deterioration, including an HIV-infected patient with a recurrence of spinal tuberculosis-IRIS symptoms 5 months after presentation secondary to a new subdural tuberculoma and 2 HIV-uninfected patients with recurrent spinal abscess (2.5 months after tuberculosis treatment initiation) and new subdural tuberculoma (8 months after tuberculosis treatment initiation), respectively. Asymptomatic radiological deterioration was seen on follow-up images in the other 3 patients, including worsening myelitis (n = 1) and increased size of tuberculoma (n = 1) in HIV-infected patients not receiving ART, and new intracranial tuberculoma in an HIV-uninfected patient. Of patients who were followed up for 9 months, 38 of 87 (44%) were able to walk at end of follow-up. Similar proportions of HIV-infected and HIV-uninfected patients showed improvement. MR imaging of the spine was repeated in 50 patients at a median follow-up of 12 months (IQR, 6-26 months). Improvement was seen in 35 of 50 patients; findings were unchanged in 8, and 7 showed deterioration with new syrinx formation (n = 3), new enhancing lesions (n = 5; due to paradoxical reaction in 3 and to poor compliance with tuberculosis treatment in 2), and cord atrophy (n = 1).
DISCUSSION
This is, to our knowledge, the largest series of patients with spinal tuberculosis thus far published. Radiculomyelitis, which was present in 77% of patients, is commonly reported as a complication of (1) TBM, through downward disease extension, or (2) tuberculosis spondylitis, through epidural disease progression [10, 22] . Primary nonbony spinal tuberculosis is the third scenario that occurs, owing to hematological dissemination to the diseased area [3, 22] . In our study, a third of patients with radiculomyelitis presented with primary intraspinal tuberculosis, emphasizing the importance of considering the diagnosis in patients with spinal symptoms without the more common features of neurological tuberculosis (ie, meningitis or spondylitis). Subdural abscess/tuberculoma [7, 10, 11, 18, [23] [24] [25] , epidural abscess (without spondylitis) [3, [26] [27] [28] , and intramedullary tuberculoma [7, 10, 27, [29] [30] [31] [32] [33] [34] are rarely reported in the literature; only case reports and small case series exist. A review of all cases of spinal complications of TBM reported 147 cases, which included subdural tuberculoma (n = 36), intramedullary tuberculoma (n = 13) and abscess (n = 13) [35] . We report 42 cases of subdural abscess (including 15 tuberculoma), 33 of intramedullary tuberculoma, and 3 of epidural abscess without spondylitis.
Noncommunicable comorbid conditions were common in HIV-uninfected patients (28% vs 8% in HIV-infected patients), and probably contributed to tuberculosis susceptibility. In particular, diabetes, a known risk factor for active tuberculosis, was present in 10% of HIV-uninfected patients [36] . Spinal tuberculosis was associated with significant morbidity. At presentation 86% were unable to walk, which probably reflects a combination of factors, such as delayed treatment initiation and extensive CNS involvement. However, the full magnitude of the long-term clinical consequences of spinal tuberculosis could not be assessed, considering the limited proportion of patients who were followed up for the duration of tuberculosis treatment (32%) and the sizable proportion of patients for whom mortality data were unavailable (37%). The gap in the literature regarding long-term outcome in spinal tuberculosis (in particular radiculomyelitis) therefore remains, which should be addressed in future studies.
Even though IALCH is not the primary referral center for patients with bony involvement, spondylitis was a frequent finding, especially in HIV-uninfected patients. There is a predilection of tuberculosis for the anterior vertebral body. Posterior element involvement is rare, especially in isolation [37] . In our study, a high proportion of patients with bony disease had posterior element involvement (28%), all in association with vertebral body disease. These findings are similar to those in a small study that detected extension of vertebral body tuberculosis into the posterior vertebral arch in 53% of patients (10 of 19) with spinal tuberculosis demonstrated by MR imaging [38] . Similar to a previous report [8] , vertebral destruction was more common in HIV-uninfected than in HIV-infected patients with spondylitis. It has been suggested that the reduced bony destruction associated with HIV occurs because of an impaired type IV hypersensitivity reaction and consequently reduced granulation formation [8] . In a study of patients with spinal tuberculosis lesions, the granulomatous architecture and macrophage activation seen at biopsy were similar in HIV-infected (n = 9) and HIV-uninfected (n = 13) patients [39] , so the reason for our observation remains unclear.
Paradoxical clinical and or radiological deterioration after effective tuberculosis treatment initiation, referred to as "paradoxical reaction", is common in both HIV-infected and HIV-uninfected patients with CNS tuberculosis [19, 40] . HIVinfected patients are particularly vulnerable to paradoxical tuberculosis-IRIS, which occurs after ART is started during tuberculosis treatment; in 1 study, neurological tuberculosis-IRIS developed in almost half of patients with TBM who started ART 2 weeks after tuberculosis treatment [21] . In our study, paradoxical reaction occurred mostly after TBM and accounted for a significant proportion of spinal tuberculosis cases. Although a minority of paradoxical reactions in HIVinfected patients (16 of 50) occurred after ART initiation, only 25 patients were known to start ART during tuberculosis treatment; furthermore, the time of ART initiation was unknown for 7 HIV-infected patients who presented with paradoxical reaction. There is no diagnostic test for paradoxical reaction or tuberculosis-IRIS and it is therefore vital to consider and exclude other causes for deterioration, such as poor adherence to tuberculosis treatment or ART, drug reactions or toxic effect, other infections, and tuberculosis drug resistance [20] .
The triad of fever, back pain, and neurological symptoms, which is suggestive of epidural abscess [41] , occurred at similar frequencies in patients with spondylitis, epi/subdural abscess, radiculomyelitis, or isolated myelitis, emphasizing its limitation in predicting the presence of epi/subdural abscess in spinal tuberculosis. However, increased CSF neutrophil counts may suggest the presence of subdural abscess in patients with suspected spinal tuberculosis. Patients with isolated tuberculosis myelitis frequently had minimal features of CSF inflammation; a diagnosis of spinal tuberculosis should therefore not be dismissed in patients with such findings.
Limitations of our study include its retrospective nature and therefore the limited information on long-term patient outcome. Complications that occurred after presentation, such as paradoxical reaction/IRIS and drug-induced hepatitis, were probably diagnosed and managed at referring hospitals and were rarely documented during follow-up; these complications probably contributed to the significant loss to follow-up. Patients with tuberculosis spondylitis evident at plain film radiography are usually referred elsewhere, and the contribution of spondylitis to spinal tuberculosis (regardless of HIV status) was probably underestimated. A relatively small proportion of patients were HIV-uninfected, and differences according to HIV status could have been missed. A minority of patients had definite neurological tuberculosis that could be explained by the large proportion of patients (50%) already receiving tuberculosis treatment at presentation. However, the majority of patients with probable neurological tuberculosis showed neurological improvement with tuberculosis treatment in the absence of other disease-specific therapies, and the remaining cases were included according to stringent criteria.
In conclusion, we describe a high frequency of previously rarely reported manifestations of spinal tuberculosis, suggesting that they are more common than what the literature implies. These findings will contribute to the clinical knowledge of spinal tuberculosis in setting with a high prevalence of tuberculosis/HIV coinfection.
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